Vox Markets Logo

NetScientific results Q&A with CEO Dr. Ilian Iliev

11:52, 13th June 2024
AudioBoom | https://audioboom.com/posts/8522932-netscientific-results-q-a-with-ceo-dr-ilian-iliev

In this interview with Vox Markets, Dr. Ilian Iliev, CEO of NetScientific (NSCI) Follow | NSCI, discusses a milestone year which saw it reach a significant milestone of managing £100 million in assets, a substantial increase from £8 million in 2020. This growth is attributed to its  strategic model focused on deep tech and life sciences venture capital investments in Europe. Dr Iliev highlighted the company’s capital-efficient investment strategy, which involves using a mix of its own funds and syndicated investments from third-party investors.

NetScientific’s model emphasizes value creation services, which involve actively engaging with portfolio companies to improve their strategies and operations. This approach ensures that the company adds tangible value beyond just financial investment. Dr Iliev explained that its operational costs are covered by fees from various services, allowing it to focus on the upside from profitable exits without diluting shareholder value.

Despite challenging market conditions, NetScientific has had a strong year, focusing on smaller investment rounds to protect and grow value modestly. It successfully raised significant funds for their portfolio companies, with £6 million syndicated by Net Scientific leading to an additional £53 million from other investors. Group income increased to £3.8 million in 2022, up from £1.8 million the previous year, while group losses decreased significantly.

Dr Iliev also discussed the recent launch of its fund management practice, which includes taking over the management of Cambridge early stage VC Martlet Capital's portfolio. This move expands its ecosystem and enhances its investment capabilities. NetScientific aims to increase assets under management to £200 million by continuing to build a strong, diversified portfolio through proactive management and strategic investments.

Looking ahead, Dr Iliev emphasized the company's commitment to becoming a leading deep tech and life sciences investor in Europe and internationally, leveraging its global network and expertise. In conclusion, NetScientific’s strategic approach, robust growth, and proactive management model positions it well for future success in the dynamic venture capital landscape.

Stock Chart | NSCI
TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Watchlist